Bioethics News

Stem Cell Breakthrough Boosts Australian Biotech Firm

( – Painful bone marrow or fat tissue donations may soon be a thing of the past after an Australian biotech company made a breakthrough in the manufacturing of stem cells. ASX-listed Cynata Therapeutics will mass manufacture mesenchymal stem cells (adult stem cells typically found in bone marrow) from just one blood donation.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.